Food News and Research

RSS

Stimulants do not increase risk of cardiovascular events in youth with ADHD

Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.

9 Feb 2012

Women in Haiti face widespread gender-based violence, sexual exploitation 2 years after earthquake

Two years after Haiti's January 2010 earthquake, a "crisis of gender-based violence and exploitation is festering -- and foreign aid efforts are still failing to protect survivor communities from harm, or to make the criminal justice system more accountable," The Nation reports.

9 Feb 2012

India's proposed food security program will face infrastructure challenges, Farm Minister says

"India's plan to roll out an ambitious food security program to give cheap foodgrains to the poor and malnourished won't succeed unless the government revamps a creaky distribution network and boosts other infrastructure such as storage and transport, Farm Minister Sharad Pawar said Wednesday," the Wall Street Journal reports.

9 Feb 2012

Few ways to stay on track on Valentine's Day

Valentine's Day has turned into a day of indulgences. Whether swimming in the eyes of the one you love over a luscious dinner or drowning your loneliness in a box of chocolates, Valentine's Day can be a big road bump on your path to better health and fitness.

9 Feb 2012

Watson settles ORTHO TRI-CYCLEN LO patent litigation with Janssen

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has reached a settlement with Janssen Pharmaceuticals, Inc. on outstanding patent litigation related to Watson's generic version of Janssen's ORTHO TRI-CYCLEN LO (norgestimate/ethinyl estradiol) tablets.

8 Feb 2012

New technologies safe and effective for fat removal

For many people, getting rid of excess fat can be a lifelong battle. Whether it is undesirable love handles, excess fat around the knees or flabby upper arms, pockets of fat can be difficult to reduce and sometimes diet and exercise are not enough to make a noticeable difference. Now, dermatologists are finding that the introduction of non-invasive fat removal technologies is opening the door for more people who are not candidates for liposuction to remove stubborn fat, safely and effectively.

8 Feb 2012

Research!America 2012 National Health Research Forum to be held on Mar. 14

Research!America 2012 National Health Research Forum-a unique interactive gathering of top policy makers. This discussion brings together heads of federal agencies for health research, as well as nationally recognized leaders from industry, academia and patient advocacy.

8 Feb 2012

Elan fourth quarter total revenue increases 18% to $271.0 million

Elan Corporation, plc today reported its fourth quarter and full-year 2011 financial results.

8 Feb 2012

Tips to understand drug-related recall

With the new year came many drug recalls. In the first six weeks of 2012, there were at least 13 drug-related recalls. Some were due to bacterial contamination. Eight distinct bacterial contaminants were identified in one over-the-counter product.

8 Feb 2012

New skin fillers and laser technologies can correct signs of aging

As we age, our skin undergoes a number of changes affecting its texture, volume and appearance. Fortunately, dermatologists can use fillers or lasers to correct the most notable signs of aging and can recommend skin care products with added ingredients that can further repair damaged skin.

8 Feb 2012

Researchers learn how to improve performance of microcantilever sensors

Researchers have learned how to improve the performance of sensors that use tiny vibrating microcantilevers to detect chemical and biological agents for applications from national security to food processing.

8 Feb 2012

Major international event focuses on responses to global sustainability challenges

The forthcoming Planet under Pressure conference is a major international event focusing on responses to global sustainability challenges.

8 Feb 2012

FDA accepts Genentech's pertuzumab BLA and grants Priority Review

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application for pertuzumab and granted Priority Review.

8 Feb 2012

Forum for Collaborative HIV Research suggests new approach for conducting Phase 3 HIV clinical trials

As the war on HIV/AIDS begins its fourth decade, medical researchers, pharmaceutical manufacturers, patient advocates and government regulators face a new and unexpected scientific challenge: how to demonstrate the safety and efficacy of promising new antiretroviral drugs when the two traditional study designs – the superiority trial and the non-inferiority trial – are no longer useful in showing improvements in both "treatment experienced" patients and those who have never received drug therapy (treatment-naive patients).

7 Feb 2012

FDA approves ivermectin lotion for treatment of head lice

Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Sklice® (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion, without nit combing.

7 Feb 2012

Roche’s new breast cancer drug Pertuzumab up for FDA review

U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.

7 Feb 2012

Vending machine to dispense “morning after pills” at college sparks debate

Now students at Shippensburg University in Pennsylvania can get the “morning after” pill by sliding $25 into a vending machine, an idea that has drawn the attention of federal regulators and raised questions about how accessible emergency contraception should be.

7 Feb 2012